ORYZON presenta los datos finales del ensayo de Fase IIa ALICE
ORYZON presenta los datos finales del ensayo de Fase IIa ALICE con tratamiento de primera línea de iadademstat y azacitidina
Leer másORYZON presenta los datos finales del ensayo de Fase IIa ALICE con tratamiento de primera línea de iadademstat y azacitidina
Leer másEl 64º Congreso y Exposición Anual de la Sociedad Americana de Hematología (ASH) tendrá lugar en Nueva Orleans (EE.UU), y
Leer másCookie | Duración | Descripción |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |